Abstract
Summary: Sarcopenia is associated with poor function and increased risk of falls and disability. This work reports a systematic review and meta-analysis of prevalence of sarcopenia in post acute inpatient rehabilitation. Sarcopenia is found to be present in approximately 50% of rehabilitation patients and its prevalence may vary with admission diagnosis. Purpose: To conduct a systematic review and meta-analysis of reported prevalence of sarcopenia in post acute inpatient rehabilitation. Methods: Systematic review conducted according to PRISMA guidelines (PROSPERO registration number CRD42016054135). Databases searched MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Methodology Register, and CINAHL. Studies considered the following: published January 1988–February 2017. Key terms are as follows: “sarcopenia” AND “inpatient rehabilitation” OR “rehabilitation” AND/OR “prevalence”. Abstracts and subsequently full studies reporting sarcopenia prevalence in adults admitted to rehabilitation reviewed irrespective of design, provided sarcopenia diagnosis included at least assessment of muscle mass. Random effect meta-analysis was conducted. Methodological quality assessment: Agency for Healthcare Research and Quality, US Department of Health and Human Services tool (MORE tool); Joanna Briggs Institute Prevalence Critical Appraisal Tool. Results: Four hundred twenty-six studies identified during initial search, 399 excluded after reviewing titles and abstracts, 21 full text articles reviewed, and six studies met inclusion criteria. Patient populations: after hip fracture (five studies), general deconditioning (one study). Identified sarcopenia prevalence ranged from 0.28 to 0.69. Pooled sarcopenia prevalence obtained with random effect meta-analysis: 0.56 (95% CI 0.46–0.65), heterogeneity I2 = 92.9%. Main quality shortcomings: lack of reporting of inter- and intra-rater reliability, lack of generalizability to other rehabilitation populations. Conclusions: Original research examining sarcopenia prevalence in inpatient rehabilitation is scarce. Patient populations studied to date are not representative of general rehabilitation population with regard to both age and admission diagnoses. Sarcopenia may be present in approximately half of rehabilitation patients and its prevalence may vary with admission diagnosis.
Similar content being viewed by others
References
Cruz-Jentoft AJ, Baeyens J, Bayer J et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423
Beaudart C, Rizzoli R, Bruyere O et al (2014) Sarcopenia: burden and challenges for Public Health. Archives of Public Health. 72:45
Phillips A, Strobl R, Vogt S, Ladwig KH, Thorand B, Grill E (2017) Sarcopenia is associated with disability status—results from the KORA-age study. Osteoporosis Int 28(7):2069–2079
Scott D, Hayes A, Sanders KM, Aitken D, Ebeling PR, Jones G (2014) Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults. Osteoporosis Int 25(1):187–193
Chang K, Hsu T, Wu W et al (2016) Association between sarcopenia and cognitive impairment: a systematic review and meta-analysis. J Am Med Dir Assoc 17(12):1164.e7–1164.e15
Cesari M, Landi F, Vellas BR, Marzetti E (2014) Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci 6:192
Cooper C, Dere W, Evans W, Kanis JA, Rizzoli R, Sayer AA, Sieber CC, Kaufman JM, Abellan van Kan G, Boonen S, Adachi J, Mitlak B, Tsouderos Y, Rolland Y, Reginster JYL (2012) Frailty and sarcopenia: definitions and outcomes parameters. Osteoporosis Int 23(7):1839–1848
He H, Liu Y, Tian Q, Papasian CJ, Hu T, Deng HW (2016) Relationship of sarcopenia and body composition with osteoporosis. Osteoporosis Int 27(2):473–482
Binkley N, Krueger D, Buehring B (2013) What’s in a name revisited: should osteoporosis and sarcopenia be considered components of ‘dysmobility syndrome’? Osteoporosis Int 24:2955–2959
Hirschfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where bone, muscle and fat collide. Osteoporosis Int 28(10):2781–2790
Cao L, Morley J (2016) Sarcopenia is recognized as an independent condition by an international classification of disease tenth revision, clinical modification (ICD-10-CM) code. J Am Med Dir Assoc 17(8):675–677
Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, de Meynard C, Donini L, Harris T, Kannt A, Keime Guibert F, onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12:249–256
Muscaritoli M, Anker S, Argiles J, Aversa Z et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) ‘cachexia-anorexia in chronic wasting diseases’ and ‘nutrition in geriatrics’. Clin Nutr 29:154–159
Dam T, Peters K, Fragala M, Cawthon P et al (2014) An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci 69:584–590
Morley J, Abbatecola A, Argiles J, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, Kirwan BA, Mantovani G, Muscaritoli M, Newman AB, Rossi-Fanelli F, Rosano GM, Roubenoff R, Schambelan M, Sokol GH, Storer TW, Vellas B, von Haehling S, Yeh SS, Anker SD, Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop (2011) Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12:403–409
Studenski S, Peters K, Alley D, Cawthon P et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69:547–558
Chen L, Liu L, Woo J, Assantachai P et al (2014) Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc 15:95–101
Landi F, Calvani R, Ortolani E, Salini S, Martone AM, Santoro L, Santoliquido A, Sisto A, Picca A, Marzetti E (2017) The association between sarcopenia and functional outcomes among older patients with hip fracture undergoing in-hospital rehabilitation. Osteoporosis Int 28(5):1569–1576
Di Monaco M, Castiglioni C, Vallero F, Di Monaco R et al (2012) Sarcopenia is more prevalent in men than in women after hip fracture: a cross sectional study of 591 inpatients. Arch Gerontol Geriatrics 55:e48–e52
Di Monaco M, Vallero F, Di Monaco R, Tappero R (2011) Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Arch Gerontol Geriatrics 52:71–74
Cruz-Jentoft A, Landi F, Schneider S, Zuniga C et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43(6):748–759
Bahat G, Tufan A, Tufan F, Kilic C, Akpinar TS, Kose M, Erten N, Karan MA, Cruz-Jentoft AJ (2016) Cut-off points to identify sarcopenia according to European working group on sarcopenia in older people (EWGSOP) definition. Clin Nutr 35(6):1557–1563
Sanchez-Rodriguez D, Marco E, Miralles R, Fayos M et al (2014) Sarcopenia, physical rehabilitation and functional outcomes of patients in a subacute geriatric care unit. Arch Gerontol Geriatrics 59:39–43
Morandi A, Onder G, Fodri L, Sanniti A et al (2015) The association between the probability of sarcopenia and functional outcomes in older patients undergoing in-hospital rehabilitation. J Am Med Dir Assoc 16(11):951–956
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med 6(6):e1000097
Rosenberg I (1989) Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 50:1231–1233
Higgins J, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org
Shamliyan T, Kane R, Ansari M, Raman G et al. Methodological evaluation of observational research (MORE)—observational studies of incidence and prevalence of chronic diseases (2011). Agency for Healthcare Research and Quality, US Department of Health and Human Services, publication No. 11-EHC008-EF)
Munn Z, Moola S, Riitano D, Lisy K (2014) The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag 3(3):123–128
Di Monaco M, Castiglioni C, De Toma E, Gardin L et al (2015) Presarcopenia and sarcopenia in hip-fracture women: prevalence and association with ability to function in activities of daily living. Aging Clin Exp Res 27:465–472
Ho A, Lee M, Chan E, Ng H, Lee CW, Ng WS, Wong SH (2016) Prevalence of pre-sarcopenia and sarcopenia in Hong Kong Chinese geriatric patients with hip fracture and its correlation with different factors. Hong Kong Med J 22:23–29
The AROC Annual report: the state of rehabilitation in Australia 2016
Morley J (2008) Sarcopenia: diagnosis and treatment. J Nutr Health Aging 12:452–456
Kaiser MJ, Bauer JM, Ramsch C, Uter W et al (2010) Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J Am Geriatr Soc 58(9):1734–1738
Pierik VD, Meskers CGM, Van Ancum JM, Numans ST et al (2017) High risk of malnutrition is associated with low muscle mass in older hospitalized patients—a prospective cohort study. BMC Geriatr 17:118
Ishii S, Tanaka T, Shibasaki K, Ouchi Y, Kikutani T, Higashiguchi T, Obuchi SP, Ishikawa-Takata K, Hirano H, Kawai H, Tsuji T, Iijima K (2014) Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int 14(Suppl. 1):93–101
Masanes F, Lojano I, Luque X, Salva A et al (2017) Cut-off points for muscle mass—not grip strength or gait speed—determine variations in sarcopenia prevalence. J Nutr Health Aging 21(7):825–829
Acknowledgments
Irina Churilov acknowledges the support of the Australian Commonwealth Government through the Australian Government Research Training Scholarship.
The Florey Institute of Neuroscience and Mental Health acknowledges the strong support of the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant.
We also acknowledge the constructive feedback from the three anonymous reviewers of this paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Electronic supplementary material
Supplementary Figure 1
Prevalence of sarcopenia, all studies, Rochester, Minnesota criteria for Di Monaco et al. (2012) – Forest plot (GIF 97 kb)
Supplementary Figure 2
Prevalence of sarcopenia, studies using only muscle mass for diagnosis, RM criteria for Di Monaco et al. (2012) – Forest plot (GIF 60 kb)
Rights and permissions
About this article
Cite this article
Churilov, I., Churilov, L., MacIsaac, R.J. et al. Systematic review and meta-analysis of prevalence of sarcopenia in post acute inpatient rehabilitation. Osteoporos Int 29, 805–812 (2018). https://doi.org/10.1007/s00198-018-4381-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-018-4381-4